Real-time enrollment status for this skin cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 4:30 AM UTC
| NCT Number | NCT06585410 |
| Recruiting Status | Recruiting |
| Condition | Skin Cancer |
| Phase | PHASE3 |
| Target Enrollment | 369 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT06585410 is currently recruiting participants. This phase3 study for skin cancer is actively seeking new participants at 47 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06585410 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06585410 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.